Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis

被引:3
|
作者
Peng, Longfei [1 ]
Cao, Zhangjun [1 ]
Wang, Qi [1 ]
Fang, Lu [1 ]
Yan, Songbai [1 ]
Xia, Dian [1 ]
Wang, Jinyou [1 ]
Bi, Liangkuan [1 ]
机构
[1] Anhui Med Univ, Hosp 2, Dept Urol, Hefei, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
microarray datasets; differentially expressed genes; Protein-protein interaction network; hub gene; renal cell carcinoma (RCC) clear cell renal cell carcinoma (CCRCC);
D O I
10.3389/fonc.2022.963483
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal cell carcinoma (RCC), as one of the most common urological malignancies, has many histologic and molecular subtypes, among which clear cell renal cell carcinoma (ccRCC) is one of the most common causes of tumor-related deaths. However, the molecular mechanism of ccRCC remains unclear. In order to identify the candidate genes that may exist in the occurrence and development of ccRCC, microarray datasets GSE6344, GSE16441, GSE36895, GSE53757 and GSE76351 had been downloaded from Gene Expression Omnibus (GEO) database. Apart from that, the differentially expressed genes (DEGs) were screened through Bioinformatics & Evolutionary Genomics. In addition, the protein-protein interaction network (PPI) was constructed, and the module analysis was performed using STRING and Cytoscape. By virtue of DAVID online database, GO/KEGG enrichment analysis of DEGs was performed. Consequently, a total of 118 DEGs were screened, including 24 up-regulated genes and 94 down-regulated genes. The plug-in MCODE of Cytoscape was adopted to analyze the most significant modules of DEGs. What's more, the genes with degree greater than 10 in DEGs were selected as the hub genes. The overall survival (OS) and disease progression free survival (DFS) of 9 hub genes were analyzed through GEPIA2 online platform. As shown by the survival analysis, SLC34A1, SLC12A3, SLC12A1, PLG, and ENO2 were closely related to the OS of ccRCC, whereas SLC34A1 and LOX were closely related to DFS. Among 11 SLC members, 6 SLC members were highly expressed in non-cancerous tissues (SLC5A2, SLC12A1, SLC12A3, SLC34A1, SLC34A2, SLC34A3). Besides, SLC12A5 and SLC12A7 were highly expressed in ccRCC. Furthermore, SLC12A1-A7, SLC34A1 and SLC34A3 were closely related to OS, whereas SLC12A2/A4/A6/A7 and SLC34A1/A3 were closely related to DFS. In addition, 5 algorithms were used to analyze hub genes, the overlapping genes were AQP2 and KCNJ1. To sum up, hub gene can help us understand the molecular mechanism of the occurrence and development of ccRCC, thereby providing a theoretical basis for the diagnosis and targeted therapy of ccRCC.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data
    Li, Xue
    Li, Mingfeng
    Zhao, Tianyu
    Zhang, Jingyu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (09): : 4288 - +
  • [22] Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney
    Ito, Hideaki
    Honda, Kazufumi
    Satow, Reiko
    Arai, Eri
    Shitashige, Miki
    Ono, Masaya
    Sakuma, Tomohiro
    Sakano, Shigeru
    Naito, Katsusuke
    Matsuyama, Hideyasu
    Yamada, Tesshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 847 - 853
  • [23] Promising Therapeutic Targets in Kidney Renal Clear Cell Carcinoma: PLXNA1 and PLXNB3
    Li, Can-Xuan
    Long, Dan
    Meng, Quan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (04) : 276 - 290
  • [24] Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
    Zhang, Ning
    Chen, Wenxin
    Gan, Zhilu
    Abudurexiti, Alimujiang
    Hu, Xiaogang
    Sang, Wei
    MEDICINE, 2020, 99 (21) : E20470
  • [25] Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets
    Naghdibadi, Mohammadjavad
    Momeni, Maryam
    Yavari, Parvin
    Gholaminejad, Alieh
    Roointan, Amir
    KIDNEY & BLOOD PRESSURE RESEARCH, 2023, 48 (01): : 135 - 150
  • [26] Screening for the Key lncRNA Targets Associated With Metastasis of Renal Clear Cell Carcinoma
    Liu, Huibin
    Chen, Peng
    Jiang, Chunyang
    Han, Jing
    Zhao, Bing
    Ma, Yujiao
    Mardan, Mahmut
    MEDICINE, 2016, 95 (02)
  • [27] Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets
    Carlo, Maria, I
    Khan, Nabeela
    Zehir, Ahmet
    Patil, Sujata
    Ged, Yasser
    Redzematovic, Almedina
    Coskey, Devyn T.
    Hyman, David M.
    Ladanyi, Marc
    Chen, Ying-Bei
    Robson, Mark
    Hakimi, A. Ari
    Lee, Chung-Han
    Feldman, Darren R.
    Gao, Jianjiong
    Chakravarty, Debyani
    Motzer, Robert J.
    Voss, Martin H.
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 18
  • [28] Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study
    Zhuang, Xiao-Yu
    Li, Ming
    Xu, Da-Ming
    Lin, Shu-Bin
    Yang, Zheng-Liang
    Xu, Teng-Yu
    Yin, Jun
    HEALTH SCIENCE REPORTS, 2024, 7 (02)
  • [29] In vitro analysis of PI3K pathway activation genes for exploring novel biomarkers and therapeutic targets in clear cell renal carcinoma
    Ali, Liaqat
    Raza, Abbas Ali
    Bin Zaheer, Ahmad
    Alhomrani, Majid
    Alamri, Abdulhakeem S.
    Alghamdi, Saleh A.
    Almalki, Abdulraheem Ali
    Alghamdi, Ahmad A.
    Khawaja, Imran
    Alhadrami, Mai
    Ramzan, Faiqah
    Jamil, Muhammad
    Ali, Mubarik
    Jabeen, Norina
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (07): : 4851 - 4872
  • [30] Antigenic targets in clear cell renal cell carcinoma
    Schindler, Nicholas R.
    Braun, David A.
    KIDNEY CANCER, 2023, 7 (01) : 81 - 91